Skip to main content
. 2016 Apr 29;7(21):31243–31256. doi: 10.18632/oncotarget.9111

Figure 4. Suppression of cancer cell vimentin by 5-MTP administration in vivo.

Figure 4

(A) Images of immunostaining of vimentin of subcutaneous A549 xenograft tumor tissues in 4 control and 4 5-MTP treated mice. (B) Quantitative analysis of vimentin-positive areas in tumors of 8 control vs. 8 5-MTP treatment mice. Each dot denotes a mouse lung tissue. Long horizontal lines represent mean values and short lines, ± SD.